vimarsana.com
Home
Live Updates
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co (NYSE:MRK) : comparemela.com
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co (NYSE:MRK)
Merck & Co is reportedly on the verge of acquiring EyeBio, an eye-drug company, for a sum of $1.3 billion. This acquisition is expected to significantly expand Merck's presence in the rapidly growing eye-care market.
Related Keywords
China ,
Japan ,
Chinese ,
Iveric Bio ,
Acceleron Pharma ,
Astellas Pharma ,
Astrazeneca ,
View Research ,
Novartis ,
Merck Co Inc ,
Wall Street Journal ,
Grand View ,
Prometheus Biosciences ,
Elon Musk Mourns Kabosu ,
Trump Embraces Crypto Donations And ,
Benzinga Neuro ,
comparemela.com © 2020. All Rights Reserved.